EMA Urged To Expand 'Unmet Needs' Definition To Support New Antibiotics
Executive Summary
The European Medicines Agency should consider policies that would allow new antibacterial products for serious and life-threatening infections to qualify for an expedited review, the pharmaceutical industry has suggested.